HIND
Vyome Holdings Inc
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2016-10-06
$2.23
+0.05 (+2.29%)
last quote
Want the full multi-source brief on HIND?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$2.23
High
$2.27
Low
$2.20
Previous close
$2.18
Fundamentals
Market cap
$15.16M
P/E (TTM)
—
P/S (TTM)
11.27x
P/B
7.95x
Gross margin
48.76%
Operating margin
-1027.78%
Net margin
-985.46%
Rev growth (YoY)
-81.26%
EPS growth (YoY)
—
ROE
-302.13%
52W high
$9.56
52W low
$1.75
Beta
1.59x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-11-12in 68 days
Q3 2026EPS est $-0.21
Recent SEC filings
CIK 1427570filing-language history →
Recent news
2026-08-28 → 2026-09-04
Benzinga · 1d
Chardan Capital Initiates Coverage On Vyome Holdings with Buy Rating, Announces Price Target of $3.5
Chardan Capital analyst Keay Nakae initiates coverage on Vyome Holdings (NASDAQ:HIND) with a Buy rating and announces Price Target of $3.5.
Benzinga · 6d
Vyome Appoints Jerry Leonard As CFO On August 27, 2026
On August 27, 2026, the board of directors (the "Board") of Vyome Holdings, Inc. (the "Company") appointed Jerry Leonard as the Company’s Chief Financial Officer. In connection with Mr. Leonard’s
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial